LSVGX
Price
$21.71
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Net Assets
116.91M
TEDIX
Price
$33.88
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Net Assets
9.63B
Interact to see
Advertisement

LSVGX vs TEDIX

LSVGX vs TEDIX Comparison Chart in %
View a ticker or compare two or three
VS
LSVGX vs. TEDIX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSVGX is a Buy and TEDIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TEDIX has more cash in the bank: 9.63B vs. LSVGX (117M). LSVGX pays higher dividends than TEDIX: LSVGX (2.10) vs TEDIX (1.53). LSVGX was incepted earlier than TEDIX: LSVGX (12 years) vs TEDIX (34 years). TEDIX (1.20) is less costly to investors than LSVGX (1.01). TEDIX is a more actively managed with annual turnover of: 42.28 vs. LSVGX (15.00). TEDIX has a lower initial minimum investment than LSVGX: TEDIX (1000) vs LSVGX (100000). LSVGX annual gain was more profitable for investors over the last year : 34.05 vs. TEDIX (7.58). LSVGX return over 5 years is better than : 80.10 vs. TEDIX (9.59).
LSVGXTEDIXLSVGX / TEDIX
Total Expense Ratio0.901.2075%
Annual Report Gross Expense Ratio1.011.2084%
Fund Existence12 years34 years-
Gain YTD28.0629.573293%
Front LoadN/A6%-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets117M9.63B1%
Annual Yield % from dividends2.101.53137%
Returns for 1 year34.057.58449%
Returns for 3 years78.4919.23408%
Returns for 5 years80.109.59835%
Returns for 10 years177.2222.13801%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNGCX82.421.00
+1.23%
American Funds New Economy R-3
OAYEX23.430.10
+0.43%
Oakmark International Small Cap Advisor
GSFPX20.60N/A
N/A
Goldman Sachs US Eq Div and Premium P
LBISX24.75N/A
N/A
BrandywineGLOBAL Div US Large Value IS
EMPTX13.05N/A
N/A
UBS Emerging Markets Equity Opp P2